Delivery Order SPE2DB22D3016-SPE2DB24FBEM1
Award Date
8/19/24
Potential Completion Date
8/20/24
Potential Value
$7.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,189.58, is for the delivery of MICROGESTIN FE 1.5-30 TAB 28S, a pharmaceutical product. The contract is a firm fixed-price Delivery Order with a completion date of September 13, 2022. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MICROGESTIN FE 1.5-30 TAB 28S. The award has a ceiling value of $3,705.83 and a completion date of July 28, 2022. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,330.42 firm-fixed-price delivery order covers the supply of MICROGESTIN FE 1.5-30 TAB 28S, a prescription medication. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which enables the company to...
This federal contract award, with ID SPE2DB20D3505|SPE2DB22FT5S2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,254.27 delivery order contract is for the supply of MICROGESTIN FE 1.5-30 TAB 28S, a prescription medication. The contract is not designated as a set-aside and was awarded through full and open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,048.51 contract is for the delivery of MICROGESTIN FE 1-20 TABLET 28S, a contraceptive medication. The award has a completion date of May 30, 2023 and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,674.45 firm-fixed-price delivery order is for the pharmaceutical product MICROGESTIN FE 1.5-30 TAB 28S. There was no set-aside used for this award. The contract has an ultimate completion date of February 15, 2024. Amerisourcebergen is a major pharmaceutical distributor that serves as a critical supplier to the Department of Defense (DoD) and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,641.30, is for the delivery of MICROGESTIN FE 1.5-30 TAB 28S, a pharmaceutical product. The award does not have a set-aside designation, indicating it was competed on an open basis. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999...
This contract award is for the delivery of Microgestin FE 1.5-30 tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $2,729.16 and an Ultimate Completion Date of December 18, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a larger Indefinite...
This federal contract award, valued at $1,139.76, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of March 5, 2025. The contract covers the delivery of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award, with ID SPE2DB20D1004|SPE2DB23FG3R3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,829.77 firm fixed-price delivery order is for the supply of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which covers a wide range of...